This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• RBC Capital analyst Brian Abrahams upgraded Neumora Therapeutics Inc (NASDAQ:NMRA) from Sector Perform to Outperform and raised the price target from $4 to $7. Neumora Therapeutics shares closed at $2.24 on Friday. See how other analysts view this stock.
• BMO Capital analyst Fadi Chamoun upgraded Old Dominion Freight Line Inc (NASDAQ:ODFL) from Market Perform to Outperform and lowered the price target from $172 to $170. Old Dominion Freight Line shares closed at $135.29 on Friday. See how other analysts view this stock.
• BNP Paribas Exane analyst Thomas Poutrieux upgraded Toast Inc (NYSE:TOST) from Neutral to Outperform and announced a $40 price target. Toast shares closed at $34.19 on Friday. See how other analysts view this stock.
• HSBC analyst Kim Fustier upgraded Chevron Corp (NYSE:CVX) from Hold to Buy and raised the price target from $166 to $169. Chevron shares closed at $151.13 on Friday. See how other analysts view this stock.
• Jones Trading analyst Debanjana Chatterjee upgraded Spyre Therapeutics Inc (NASDAQ:SYRE) from Hold to Buy and announced a $64 price target. Spyre Therapeutics shares closed at $30.00 on Friday. See how other analysts view this stock.

Considering buying CVX stock? Here’s what analysts think:

Read This Next:

• Wall Street’s Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 13% Dividend Yields

Photo via Shutetrstock